chrisvoncsefalvay/vaers-outcomes huggingface dataset:
stomach sick; nausea; left arm hurting; corporal temperature of 99.6F; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm hurting), BODY TEMPERATURE INCREASED (corporal temperature of 99.6F), ABDOMINAL DISCOMFORT (stomach sick) and NAUSEA (nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L2OA) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (left arm hurting) and BODY TEMPERATURE INCREASED (corporal temperature of 99.6F). On 17-Jan-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach sick) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) 16-Jan-2021 at a dose of UNK dosage form. On 17-Jan-2021, BODY TEMPERATURE INCREASED (corporal temperature of 99.6F) had resolved. On 18-Jan-2021, PAIN IN EXTREMITY (left arm hurting), ABDOMINAL DISCOMFORT (stomach sick) and NAUSEA (nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient takes blood pressure medication regularly.
High Fever 101.6 F, lethargy, Confusion, Muscle/Joint aches and pains, headache, Tiredness, Chills all started about 17 hours after the shot(vaccine) Fever finally broke after taking 1000mg Tylenol. About 40 hours after the vaccine I felt normal again with just a mild aches and pains in joints.
Patient with history of 3 COVID vaccines who admitted to hospital with COVID detected PCR.  No hypoxia noted during stay.  Provider d/c note:  "Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) The patient per the report of her husband was in her normal mental state earlier in the day and then when he returned after getting some food he found her in the bathroom very confused.  As she had an apparently abrupt change in mental status she was evaluated with a code stroke.  There were no acute lesions on CT head or perfusion study.  There were mild stenoses in the carotids.  Patient has a history of frequent urinary tract infections and her urinalysis here was abnormal.  Patient admitted for altered mental status.(HPI per Dr)   Hospital Course: No notes on file Patient is an 86yr old female with a history of HTN, CAD, CKD, HLD, Osteoporosis on denosumab, Depression, Cognitive decline who presented with confusion AMS and found to have UTI. Today she is seen sitting in chair out of bed. She says she feels ok.    Acute Encephalopathy secondary to Klebsiella UTI - CT head unremarkable. Urine culture grew >100,000 CFU. She received 4 days of IV Ceftriaxone. She was switched to nitrofurantoin which was apparently prescribed by her urologists but due to her CKD, I switched it to keflex on discharge.    Discharge Exam: General - Elderly female, not in obvious distress HEENT - NC AT Heart - S1 S2 RRR Lung - CTAB Ext - No LE edema Neuro - AAAO to person, partially to place and time. "
Information has been received from a physician assistant concerning a female under 18 year old who on unspecified date was vaccinated with her third dose of GARDASIL (lot number, route and site not reported) About 6 weeks after the third dose of GARDASIL the patient broke out in a rash all over her body. The patient had gone to a dermatologist who diagnosed the patient with lichen nitidus. The physician assistant was not sure if it was from the GARDASIL since the patient had no reaction with the first and second dose of GARDASIL, but the dermatologist believed it was from GARDASIL. Subsequently, the patient recovered from lichen nitidus. Additional information has been requested.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient experienced dizziness and proceeded to faint and fall off her seat. She regained consciousness within approximately 20 seconds. Patient also got a cut above her eye due to the fall.
Splitting trident occipital headache/ Dull ache in frontal skull region; This is a spontaneous report from a contactable other healthcare professional (patient). A 34-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EK5730, expiration date not reported) via an unspecified route of administration on the left arm on 23Dec2020 16:00 at a single dose for COVID-19 immunization. Medical history included asthma, rheumatoid arthritis, Raynaud's and allergies: latex, nickel, erythromycin. Concomitant medication included albuterol [salbutamol] (ALBUTEROL [SALBUTAMOL]), mometasone furoate (FLONASE [MOMETASONE FUROATE]), vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), colecalciferol (VITAMIN D [COLECALCIFEROL]) and multivitamin. On 24Dec2020, 1 day post 1st injection the patient had splitting trident occipital headache - lasted 24 hrs. Dull ache in frontal skull region two days after that. No treatment was received. The facility where the vaccine was administered was the workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. Outcome of the event was unknown.
Headache, dizziness, chills, injection site redness, shaking, dry heaves.
Runny nose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient in his 60's received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 7 decade as 1st dose, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RHINORRHOEA (non-serious), outcome "unknown", described as "Runny nose".  Additional information: The report is cross referenced to report ID. The caller called to report having runny nose that began a week after her first Covid vaccine. During the call she stated that she had a friend that also reported having a runny nose. The caller was only only able to provide the sex, approximate age of 68 years old and race of the patient. She was unable to provide any other details.   No follow-up attempts are possible. No further information is expected.
all tested positive for Covid last week. No hospitalizations resulted.; all tested positive for Covid last week. No hospitalizations resulted.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 46-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 01Jun2022, outcome "unknown" and all described as "all tested positive for Covid last week. No hospitalizations resulted.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (01Jun2022) Positive, notes: My wife tested positive on 01Jun. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: As reported His Wife and all three of the children who were all fully vaccinated with Pfizer Covid vaccine all tested positive for Covid last week. No hospitalizations resulted. His wife was 46 years old and has had other medical issues. She was prescribed Paxlovid and reports a foul taste in her mouth after starting the initial does on 02Jun2022.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Severe vomiting, diarrhea, fatigue, headache, unable to get out of bed. Still ongoing three days later
This initial spontaneous case was received from other health professional (pharmacist) on 13-Nov-2017, concerning a 67-year-old, elderly, male patient. The patient's historical drug included: received high dose of flu vaccine 1.5 months ago. On 13-Nov-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch no: 179201 and expiry date: Jun-2018). It was reported that the patient received FLUAD after receiving high dose of flu vaccine 1.5 months ago (explicitly coded as inappropriate schedule of vaccine administered) and no adverse effect was noted. The reporter assessed the events as non-serious.
Heart attack; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDIAL INFARCTION (Heart attack) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On 16-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced MYOCARDIAL INFARCTION (Heart attack) (seriousness criteria death and medically significant). The patient died in December 2021. The reported cause of death was Heart attack. It is unknown if an autopsy was performed.            No concomitant medication reported.   No treatment Medication reported.  It was mentioned that the patient was editor at a local newspaper who died of heart attack less than one day later booster dose. It was stated that the media lied as a local newspaper reported only death while (unlisted country) news reported death due to shot.  Company comment: This case concerns a  49-year-old male patient, with no reported medical history, who experienced the serious, unexpected events myocardial infarction one day after the third dose of mRNA-1273 (Moderna COVID-19 Vaccine). The patient died and reported cause of death was heart attack. It is unknown if an autopsy was performed. No further information was provided. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2021: Added information in I-narrative supplement.; Sender's Comments: This case concerns a  49-year-old male patient, with no reported medical history, who experienced the serious, unexpected events myocardial infarction one day after the third dose of mRNA-1273 (Moderna COVID-19 Vaccine). The patient died and reported cause of death was heart attack. It is unknown if an autopsy was performed. No further information was provided. The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.; Reported Cause(s) of Death: Heart attack
Serious, weird reaction/had a strong, whole body heat, and flushing; Serious, weird reaction/had a strong, whole body heat, and flushing; Serious, weird reaction/tachycardic; Serious, weird reaction/had palpitations; This is a spontaneous report from a contactable nurse. This nurse reported similar events for 6 patients. This is 5th of 6 reports.  A patient of unspecified gender and age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 28Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter did not know if the patient had received any other vaccines at the same time as the COVID-19 Vaccine, and if the patient had received any other vaccines within the last 4 weeks. It was reporter that the reporter's friend texted her last night, on 30Dec2020, at around midnight. The reporter, and 5 other registered nurses she works with in a hospital, received the COVID-19 vaccine at the same time and had the same exact symptoms she experienced. They had a serious reaction right after receiving the COVID-19 Vaccine. The patient had a weird reaction right after being injected with the COVID-19 Vaccine. The patient had a strong, whole body heat, and flushing. The patient became tachycardic and had palpitations that lasted a few minutes. The tachycardia and palpitations then slowly resolved in less than 5 minutes. The patient had no other symptoms after receiving the COVID-19 Vaccine. The registered nurse who was monitoring the people who received the COVID-19 Vaccine indicated that the same feeling had occurred in many other workers who had received the COVID-19 vaccine.  For treatment information, the reporter didn't believe the patient received any medical attention. Reporter believed that the patient just waited symptoms out, and within 5 minutes the symptoms had gone away. The outcome of the events was recovered on 28Dec2020.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the compatible temporal association, the vaccination with BNT162B2 might play a contributory role in triggering the onset of the events flushing, feeling hot, tachycardia and palpitations. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021001345 same reporter/drug/event, different patient.
Walked around store right after I got it. Within 10 minutes my heart was racing, felt dizzy, and started shaking. Went back over to the pharmacy and told them. They told me to sit down. My whole body was shaking at this point. The whole event lasted about 20 minutes and I started to feel better so I left. It?s been 2.5 hours. I called in sick to work. My heart rate is still high but not like it was in the store. I?m not dizzy and not shaking right now. My chest hurts though and I?m super tired.
pt exp sz p/vax (<30 secs) p/24 hrs; no fever;
ACUTE NON ST ELEVATION MI ACUTE HYPOXEMIC RESPIRATORY FAILURE 11/17/2022,  11/22/2022,  11/14/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
patient stated that Saturday night ( same day she get the shoots ) she said her arm started to swell . it started in the inner side of her arm and spread to the outer part.  today there is still some redness left and still a bit red but she said it was worse before and now it looks a bit better.
raised areas on skin-not red;some small some larger;itching @ times;came to clinic on 14APR97 in person;dx pityriasis rosea (not hep b vax related);
Patient admitted 12/18/22 stating he had a flu shot 6 days prior (attempted to confirm but no flu vaccine information available in system). He was complaining of weakness to both lower extremities that began shortly after receiving the flu vaccine and then began to move into his arms as well to the point that was unable to walk and fell multiple times. Initially seen in ER and then admitted as an inpatient with initial diagnosis of Guillian-Barre syndrome. Neurology was consulted and saw 12/19 and concurred with this diagnosis and ordered IgG infusion (Privigen) 40Gm daily x 5 doses.
The nurse reconstituted the vaccine and then had to be gone for half hour before administering Rabavert; The nurse reconstituted the vaccine and then had to be gone for half hour before administering Rabavert; Case reference number US-BN-2022-001079 is a spontaneous case report initially received on 13-May-2022 from a pharmacist via Communications (reference number: USBAV22-0184) and concerns a patient of unknown age or gender.  The patient's medical history and concomitant medication details were not provided.  On an unknown date, the patient was vaccinated with RabAvert vaccine ((Inactivated, Strain Flury LEP) (PCEC); batch number was not provided), at a dose of 2.5 IU, administered intramuscularly, for unknown indication. It was also reported that the nurse reconstituted the vaccine and then had to be gone half an hour before administering the vaccine to the patient (explicitly coded as 'vaccine preparation error' and 'product administration error').  At the time of this report, it was unknown if the patient experienced any adverse events.  No further information was provided.; Reporter's Comments: A patient of unknown age or gender was vaccinated with RabAvert for unknown indication. Reportedly, the nurse reconstituted the vaccine and then had to be gone half an hour before administering the vaccine to the patient, which is considered as product preparation error and product administration error. No associated adverse events have been reported with the reported medication error. Product preparation error and product administration error are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product preparation error and product administration error have been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A patient of unknown age or gender was vaccinated with RabAvert for unknown indication. Reportedly, the nurse reconstituted the vaccine and then had to be gone half an hour before administering the vaccine to the patient, which is considered as product preparation error and product administration error. No associated adverse events have been reported with the reported medication error. Product preparation error and product administration error are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product preparation error and product administration error have been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
positive test result for covid-19 vaccine; This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer (patient herself) of an unspecified age received bnt162b2 (BNT162B2, Formulation: Solution for injection), dose 1 via an unspecified route of administration on 23Jan2021 (Lot number and Expiry date was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On 26Jan2021, the patient experienced positive test result for covid-19 vaccine. The patient underwent lab tests and procedures on 26Jan2021 which included sars-cov-1 test: results positive covid-19 vaccine. The outcome of the event was unknown.  Information of lot and batch number has been requested.
blurry vision; extreme dizziness; felt clammy; really bad reaction; headache,; nausea; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (blurry vision), DIZZINESS (extreme dizziness), COLD SWEAT (felt clammy), ADVERSE REACTION (really bad reaction) and HEADACHE (headache,) in a 37-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart disorder.    On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Aug-2021, the patient experienced VISION BLURRED (blurry vision), DIZZINESS (extreme dizziness), COLD SWEAT (felt clammy), ADVERSE REACTION (really bad reaction), HEADACHE (headache,) and NAUSEA (nausea). At the time of the report, VISION BLURRED (blurry vision), DIZZINESS (extreme dizziness) and NAUSEA (nausea) had resolved and COLD SWEAT (felt clammy), ADVERSE REACTION (really bad reaction) and HEADACHE (headache,) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Aug-2021, Heart rate: increased (High) High heart rate for 15 minutes..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information was provided. Three minutes after the first dose, really bad reaction with high heart rate for 15 minutes, blurry vision, headache, nausea, extreme dizziness was reported. The patient was not sweating but felt clammy. The patient stated that his blurry vision did not last as long but his nausea and dizziness lasted for 3 to 4 hours.
headache; body aches; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) and MYALGIA (body aches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache) and MYALGIA (body aches). At the time of the report, HEADACHE (headache) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       The concomitant medications were not reported. The treatment information was not provided.
This spontaneous report as received from a pharmacist refers to a 67 year old female patient with Macrodantin allergy, latex allergy, peanuts allergy and statin allergy. The patient had no pertinent medical history. On 14-AUG-2013 the patient was vaccinated with ZOSTAVAX (lot # J001007, exp. date 24-APR-2014) 0.65 ml, subcutaneous. Concomitant medications were not reported. Pharmacist stated that on 14-AUG-2013, 3 hours after receive ZOSTAVAX, patient felt dizzy. Pharmacist stated patient continued "not feeling well" at 8 hours post vaccination and experienced throat tightness. Pharmacist stated patient reported she went to unspecified urgent care clinic where it was diagnosed as "a sort of allergic reaction" and patient was given unspecified antihistamines. Pharmacist stated patient "was fine" on 19-AUG-2013. No lab diagnostics studies were performed. The relationship between ZOSTAVAX and the allergic reaction was not reported. Additional information has been requested.
MODERNA vaccine caused me to be excessively tired for 6 days straight. Sleeping 12+ hours plus naps. On day 7 I developed a red hard bump at injection site.
First 8 hours (April 8 and 9th, 2021) I  became extremely nauseous, and vomited on and off for the next  48 hours. First 24 hours (April 9, 2021) Fever, chills, sweating. First month: By May 2021 I quit my internship because I stayed nauseous and had really bad headaches, along with uncontrollable crying and anxiety. I had depression and extreme fatigue but couldn't sleep. I got epilepsy. I had dizzy spells and kept passing out. Multiple times a day I felt like I was going to pass out, I got splotches of  vision and couldn't drive at night anymore. These symptoms lasted for 4 months. In July of 2021, I was diagnosed with POTS and started treatment with a clinic. I dropped out of college, (at the time I was a senior).  I can barely do any  exercise or handle anything stressful. I've improved a little but now take blood thinners, vitamin B shots, N-Acetyl-L-Cysteine supplements and vagus nerve vitamins.
Moderna Bivalent Booster was given to patient was only given half the dose 0.25mcg not the full dose 0.5mcg.
10:30PM woke up with fever 103.7 R, Grabbing head vomiting and had non-stop crying from 10:30PM to 5:00AM. Seen in Dr's office on 10/11/2005 at 3:30PM. No reaction noted at injection site. No ear infection Dx.
Pt hosp with ifx (R) sh arthr 11/20-27/12.